Emerging Technologies to Target Drug Delivery to the Skin - the Role of Crystals and Carrier-Based Systems in the Case Study of Dapsone
- PMID: 33169237
- DOI: 10.1007/s11095-020-02951-4
Emerging Technologies to Target Drug Delivery to the Skin - the Role of Crystals and Carrier-Based Systems in the Case Study of Dapsone
Abstract
Dapsone (DAP) is a long-established molecule that remains a promising therapeutic agent for various diseases mainly because it combines antimicrobial and anti-inflammatory activities. Its oral application, however, is limited by the dose-dependent hematological side effects that may rise from systemic exposure. As an alternative to overcome this limitation, the administration of DAP to the skin has witnessed prominent interest in the past 20 years, particularly when applied to the treatment of dermatological disorders. In this review, all technological strategies proposed to the topical delivery of DAP are presented. Most of the reported studies have been devoted to the clinical use and safety of a gel formulation containing both solubilized and microcrystalline drug, however, the technological characteristics of such preparation are still missing. In parallel, the incorporation of DAP into vesicular and particulate carriers (e.g. nano- and microemulsions, niosomes, invasomes, bilosomes, cubosomes, solid lipid nanoparticles, nanostructured lipid carriers, polymeric nanocapsules and polymer-lipid-polymer hybrid nanoparticles) appears to be an alternative to provide greater drug release control, enhanced drug solubilization and follicular targeting. Indeed, the main application of DAP topical formulations reported in the literature was the treatment of acne vulgaris, a disease located in the hair follicle. Other diseases affecting different regions of the skin (e.g. cutaneous lupus erythematosus and cutaneous leishmaniasis), however, may also benefit from a topical therapeutic regimen containing DAP. Therefore, the investigation of appendageal route in comparison to passive transmembrane diffusion as a function of targeted disease, as well as pharmacokinetic studies, are perspectives highlighted herein. Such studies may drive future efforts towards the rational development of safe and effective technologies to deliver DAP to the skin. Graphical abstract.
Keywords: crystals; dapsone; gels; nanoparticles; topical drug delivery.
Similar articles
-
Bilosomes as a novel carrier for the cutaneous delivery for dapsone as a potential treatment of acne: preparation, characterization and in vivo skin deposition assay.J Liposome Res. 2020 Mar;30(1):1-11. doi: 10.1080/08982104.2019.1577256. Epub 2019 Jul 15. J Liposome Res. 2020. PMID: 31010357
-
Formulation and Optimization of Topical Solid Lipid Nanoparticles based Gel of Dapsone Using Design of Experiment.Pharm Nanotechnol. 2018;6(4):264-275. doi: 10.2174/2211738506666181105141522. Pharm Nanotechnol. 2018. PMID: 30394227
-
Dapsone-Loaded Invasomes as a Potential Treatment of Acne: Preparation, Characterization, and In Vivo Skin Deposition Assay.AAPS PharmSciTech. 2018 Jul;19(5):2174-2184. doi: 10.1208/s12249-018-1025-0. Epub 2018 May 3. AAPS PharmSciTech. 2018. PMID: 29725903
-
Insightful exploring of advanced nanocarriers for the topical/transdermal treatment of skin diseases.Pharm Dev Technol. 2021 Dec;26(10):1136-1157. doi: 10.1080/10837450.2021.2004606. Epub 2021 Nov 18. Pharm Dev Technol. 2021. PMID: 34751091 Review.
-
Dapsone 5% gel: a review of its efficacy and safety in the treatment of acne vulgaris.Am J Clin Dermatol. 2009;10(4):221-7. doi: 10.2165/00128071-200910040-00002. Am J Clin Dermatol. 2009. PMID: 19489655 Review.
Cited by
-
Leprosy: Comprehensive insights into pathology, immunology, and cutting-edge treatment strategies, integrating nanoparticles and ethnomedicinal plants.Front Pharmacol. 2024 May 16;15:1361641. doi: 10.3389/fphar.2024.1361641. eCollection 2024. Front Pharmacol. 2024. PMID: 38818380 Free PMC article. Review.
-
Cathelicidins: Opportunities and Challenges in Skin Therapeutics and Clinical Translation.Antibiotics (Basel). 2024 Dec 24;14(1):1. doi: 10.3390/antibiotics14010001. Antibiotics (Basel). 2024. PMID: 39858288 Free PMC article. Review.
-
D-optimal mixture design for optimization of topical dapsone niosomes: in vitro characterization and in vivo activity against Cutibacterium acnes.Drug Deliv. 2022 Dec;29(1):821-836. doi: 10.1080/10717544.2022.2048131. Drug Deliv. 2022. PMID: 35266431 Free PMC article.
-
Experimental and Theoretical Insights into the Intermolecular Interactions in Saturated Systems of Dapsone in Conventional and Deep Eutectic Solvents.Molecules. 2024 Apr 11;29(8):1743. doi: 10.3390/molecules29081743. Molecules. 2024. PMID: 38675562 Free PMC article.
-
MiR-197 Inhibitor Loaded AbCD133@MSNs@GNR Affects the Development of Prostate Cancer Through Targeting ITGAV.Front Cell Dev Biol. 2021 Jun 14;9:646884. doi: 10.3389/fcell.2021.646884. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34195187 Free PMC article.
References
-
- Rang HP, Dale MM, Ritter JM, Flower RJ. Rang & Dale’s pharmacology. 7th ed. London: Churchill Livingstone; 2011. 792 p.
-
- Brunton L, Chabner B, Knollman B. Goodman and Gilman’s the pharmacological basis of therapeutics, twelfth edition. 12th ed. McGraw-Hill Education: New York City; 2011. 1808 p.
-
- Remington JP. In: Allen LV, Adejare A, Desselle S, Felton L, Moffat A, editors. Remington - the science and practice of pharmacy. 22nd ed. London: Pharmaceutical Press; 2012. 3024 p.
-
- Wozel G, Blasum C. Dapsone in dermatology and beyond. Arch Dermatol Res. 2014;306(2):103–24. - PubMed
-
- Gillis TP. Mycobacterium leprae. In: Tang Y-W, Sussman M, Liu D, Poxton I, Shwartzman J, editors. Molecular medical microbiology. 2nd ed. Boston: Academic Press; 2015. p. 1655–68.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous